Plain-English translation of NCT06883344 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether automated insulin delivery (AID) systems—which automatically adjust insulin doses throughout the day and night—can safely manage blood sugar during labor and delivery for pregnant people with type 1 diabetes. Right now, hospitals use intravenous (IV) insulin during labor, which requires constant monitoring and manual adjustments. Researchers want to see if the automated system can do a better job keeping blood sugar in a healthy range and if it makes labor easier and more satisfying for patients.
Managing blood sugar during labor is tricky and stressful—blood sugar can swing unpredictably, which affects both mother and baby. This medication has been a game-changer for many people with type 1 diabetes in everyday life, but no one has tested whether it works well during the intense, fast-changing environment of labor and delivery.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll be randomly assigned to either use your automated insulin delivery system during labor or receive the standard IV insulin treatment. Researchers will track your blood sugar and your baby's blood sugar throughout labor and delivery, then compare how well each approach works. You'll also answer questions about your experience and satisfaction with the method you received. The study will follow you and your baby for the hospital stay and early postpartum period to make sure everything is healthy.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States